Weight Management

Despite the surge in new diabetes cases, the treatment options in in children remain limited.

Chemotherapy may increase inflammatory biomarkers that can impact the diversity of the gut microbiome, leading to serious anthropomorphic changes among women treated for early-stage breast cancer.

Study shows equivalent overall survival among younger adults with acute lymphoblastic leukemia aged 15 to 29 and older adults aged 30 to 50 with normal BMI.

Pharmaceuticals are a critical and often lifesaving tool for managing disease, but we will never solve our chronic disease crisis through a mindset of mere management.

The results of the study were presented at the 83rd Scientific Sessions of the American Diabetes Association in San Diego, California and were also published in The Lancet.

Pharmacists can address the needs of health care consumers earlier in the care journey by building interpersonal relationships and community trust, as well as by leading institutional and public policy reform.

Research notes that modifiable lifestyle factors, such as overconsumption of food and vitamin deficiency, can affect pregnancy.

Available pharmacological therapies have shown high efficacy in achieving weight loss.

Individuals administered oral semaglutide 50 mg achieved a statistically significant weight loss of approximately 17.4% after 68 weeks, according to Novo Nordisk.

Eating regimen shows many health benefits, but the diet may not be appropriate for all patients.

The use of semaglutide for adolescents was included in recent pediatric guidelines, though there are few studies assessing the drug in this patient population.

Weight loss that began as far as 2 years before a lung cancer diagnosis was associated with a risk of cancer.

At least 150 minutes per week of moderate intensity aerobic activity, or 75 minutes of vigorous intensity aerobic activity found to improve outcomes in patients with flu or pneumonia.

Options abound, but pharmacists should address barriers to prevent inequities for patients when they seek treatment.

BI 456906 activates the GLP-1 and glucagon receptors that help to control metabolic function, and could potentially offer clinically relevant benefits for those living with obesity or overweight without type 2 diabetes.

Dr. Christina Madison speaks with Walter Oronsaye PharmD, RPh, known as the Phit Pharmacist, about nutrition and social media as a pharmacist.

An increase in the use of GLP-1 agonists for weight loss is affecting patients with diabetes who rely on these medications.

Nearly 18-times more patients on trizepatide 15 mg achieved a body weight reduction of 15% or more compared to placebo.

Prediagnostic weight loss could be an important marker for colorectal cancer diagnosis.

A severe reduction in food intake lasting just 2 weeks caused damage to the heart and kidneys that appeared to be irreversible, even after the body weight was restored.

Limiting added or free sugar is recommended to reduce the adverse effects, especially in cardiometabolic disease.

The FDA’s temporary Guidance for 503A compounding of shortage drugs was meant to be temporary and withdrawn once COVID-19 ended.

Health benefits last for at least 5 years if shedding pounds occur via a lifestyle change program, the results of a research review show.

Thought-provoking economic, ethical conundrums accompany recent explosion in growth of glucagon-like peptide-1 products for medically assisted weight loss

Data indicated that waist-to-height ratio is a better indicator of outcomes in patients with HF than body mass index.